Creatine clinical trials

Explore recruiting creatine clinical trials.

Recruiting creatine studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Creatine trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Open label, single-center pilot study to investigate enzyme replacement therapy (ERT) frequency reduction from 2 to 4 weeks in a subgroup of elderly patients with late-onset Pompe disease

Netherlands

Therapeutic use (Phase IV) EU CTIS Study details

Phase 1/2 Dose-Escalation Study to Evaluate the Safety, Tolerability, and Efficacy of a Single Intravenous Infusion of SPK-3006 in Adults with Late-Onset Pompe Disease

Germany

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

A Phase I/II, open-label, dose escalation study to evaluate the safety of 2 doses of intravenous ATA-200, an adeno-associated viral vector carrying the human gamma-sarcoglycan gene, in patients with gamma-sarcoglycanopathy (limb-girdle muscular dystrophy LGMDR5, formerly LGMD2C).

France, Italy

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

A Phase 2 Randomized, Double-blind, Placebo-controlled Study of the Effect of EDG-5506 on Biomarker Response to Exercise in Adults with Becker Muscular Dystrophy, McArdle Disease, or Limb-Girdle Muscular Dystrophy

Denmark

Therapeutic exploratory (Phase II) EU CTIS Study details

Pulse Glucocorticoid Therapy In Patients With ST-Segment Elevation Myocardial Infarction (PULSE-MI)

Denmark

Therapeutic exploratory (Phase II) EU CTIS Study details

A randomized, double-blind, placebo-controlled Phase II proof of concept study evaluating efficacy and safety of Upadacitinib in patients with idiopathic inflammatory myopathies after withdrawal of intravenous immunoglobulins (IVIG) (IVIG-Spare)

Austria

Therapeutic exploratory (Phase II) EU CTIS Study details

Creatine trials by city

Creatine in Toronto Creatine in Vancouver Creatine in Montreal Creatine in Calgary Creatine in Edmonton Creatine in Ottawa Creatine in Winnipeg Creatine in Quebec City Creatine in Hamilton Creatine in Kitchener Creatine in London Creatine in Halifax Creatine in New York Creatine in Los Angeles Creatine in Chicago Creatine in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease